BC

Birchview Capital Portfolio holdings

AUM $101M
This Quarter Return
-0.71%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$108M
AUM Growth
+$108M
Cap. Flow
-$5.67M
Cap. Flow %
-5.24%
Top 10 Hldgs %
67.6%
Holding
63
New
4
Increased
7
Reduced
9
Closed
3

Top Buys

1
CORT icon
Corcept Therapeutics
CORT
$780K
2
PRTA icon
Prothena Corp
PRTA
$702K
3
XOM icon
Exxon Mobil
XOM
$673K
4
BDSX icon
Biodesix
BDSX
$531K
5
CSTL icon
Castle Biosciences
CSTL
$435K

Top Sells

1
NBIX icon
Neurocrine Biosciences
NBIX
$4.82M
2
INBX
Inhibrx, Inc. Common Stock
INBX
$1.69M
3
PXD
Pioneer Natural Resource Co.
PXD
$998K
4
BMY icon
Bristol-Myers Squibb
BMY
$639K
5
ELUT icon
Elutia
ELUT
$514K

Sector Composition

1 Healthcare 94.57%
2 Energy 5.43%
3 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PGNY icon
26
Progyny
PGNY
$2.04B
$629K 0.58%
22,000
– –
TXG icon
27
10x Genomics
TXG
$1.74B
$584K 0.54%
30,000
– –
KNSA icon
28
Kiniksa Pharmaceuticals
KNSA
$2.48B
$560K 0.52%
30,000
– –
KALV icon
29
KalVista Pharmaceuticals
KALV
$678M
$542K 0.5%
46,000
– –
CYTK icon
30
Cytokinetics
CYTK
$4.23B
$542K 0.5%
10,000
– –
APLS icon
31
Apellis Pharmaceuticals
APLS
$3.48B
$537K 0.5%
14,000
-4,000
-22% -$153K
HALO icon
32
Halozyme
HALO
$8.56B
$524K 0.48%
10,000
– –
CHRS icon
33
Coherus Oncology, Inc. Common Stock
CHRS
$135M
$467K 0.43%
270,000
– –
KPTI icon
34
Karyopharm Therapeutics
KPTI
$61.7M
$408K 0.38%
469,832
– –
ARVN icon
35
Arvinas
ARVN
$568M
$399K 0.37%
15,000
– –
SRPT icon
36
Sarepta Therapeutics
SRPT
$1.78B
$395K 0.37%
2,500
– –
XENE icon
37
Xenon Pharmaceuticals
XENE
$2.98B
$390K 0.36%
10,000
– –
AXDX
38
DELISTED
Accelerate Diagnostics
AXDX
$381K 0.35%
325,239
– –
SWTX
39
DELISTED
SpringWorks Therapeutics
SWTX
$377K 0.35%
10,000
– –
CGEM icon
40
Cullinan Oncology
CGEM
$445M
$349K 0.32%
20,000
-5,114
-20% -$89.2K
NVCR icon
41
NovoCure
NVCR
$1.38B
$343K 0.32%
+20,000
New +$343K
AXSM icon
42
Axsome Therapeutics
AXSM
$6.05B
$322K 0.3%
4,000
– –
KROS icon
43
Keros Therapeutics
KROS
$618M
$320K 0.3%
7,000
– –
BLUE
44
DELISTED
bluebird bio
BLUE
$306K 0.28%
311,200
-10,000
-3% -$9.84K
FOLD icon
45
Amicus Therapeutics
FOLD
$2.34B
$278K 0.26%
28,000
– –
BHVN
46
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$256K 0.24%
7,365
– –
BCRX icon
47
BioCryst Pharmaceuticals
BCRX
$1.74B
$247K 0.23%
40,000
+20,000
+100% +$124K
XNCR icon
48
Xencor
XNCR
$580M
$233K 0.22%
12,300
– –
WVE icon
49
Wave Life Sciences
WVE
$1.53B
$200K 0.18%
40,000
– –
GTHX
50
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$182K 0.17%
80,000
– –
1
2
3